Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05963490
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2023-07-19
Brief Title:
Regorafenib Alone or in Combination With HypofractionatedLow-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
FDRT-2023-118-3237
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhen Zhang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None